Technical Analysis for IXI - Ixico Plc

Grade Last Price % Change Price Change
F 79.5 8.16% 6.00
IXI closed up 8.16 percent on Friday, April 16, 2021, on 1.23 times normal volume. It ran into resistance at its 50 day moving average. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up
Historical IXI trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
New Uptrend Bullish 0.00%
Wide Range Bar Range Expansion 0.00%
Stochastic Reached Overbought Strength 0.00%
Multiple of Ten Bearish Other 0.00%
Weak + Overbought Other 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Older End-of-Day Signals for IXI ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Ixico Plc Description

IXICO plc is a brain health company. The Company's brain health focus includes Alzheimer's disease, Huntington's disease, Parkinson's disease, behavioral health and adolescent mental health. It is a provider of clinical trials services to pharmaceutical companies. Its products include Assessa, mehealth, MyBrainBook and TrialTracker. Assessa is a decision-support tool for healthcare professionals looking to diagnose dementia and detect the underlying causes. mehealth is an online software for clinicians at the point-of-care to support decision making and improve the monitoring and treatment of patients. MyBrainBook is a digital platform to improve the quality of life and service delivery for people living with dementia and their supporters. TrialTracker is a Web-based system that allows users to track their imaging-based research study or clinical trial in real time. It is also collaborating with partners to develop companion digital health products.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Healthcare Support Software Research Pharmaceutical Quality Medicine Clinic Monitoring Disease Labor Clinical Trial Avio Imaging Real Time Rtt Tracker Eim Behavior Healthcare Professionals Mental Health Pharmaceutical Companies Health Products Alzheimer's Disease Dementia Aging Associated Diseases Learning Disabilities Parkinson's Disease Psychiatric Diagnosis

Is IXI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 127.0
52 Week Low 55.55
Average Volume 188,294
200-Day Moving Average 88.23
50-Day Moving Average 84.89
20-Day Moving Average 74.85
10-Day Moving Average 71.70
Average True Range 5.34
ADX 28.39
+DI 34.27
-DI 27.37
Chandelier Exit (Long, 3 ATRs ) 98.97
Chandelier Exit (Short, 3 ATRs ) 71.58
Upper Bollinger Band 103.00
Lower Bollinger Band 46.70
Percent B (%b) 0.58
BandWidth 75.22
MACD Line -3.66
MACD Signal Line -4.99
MACD Histogram 1.3272
Fundamentals Value
Market Cap 37.44 Million
Num Shares 47.1 Million
EPS 2.00
Price-to-Earnings (P/E) Ratio 39.75
Price-to-Sales 5.49
Price-to-Book 5.68
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 97.50
Resistance 3 (R3) 97.33 91.17 94.50
Resistance 2 (R2) 91.17 86.58 91.25 93.50
Resistance 1 (R1) 85.33 83.75 88.25 85.50 92.50
Pivot Point 79.17 79.17 80.63 79.25 79.17
Support 1 (S1) 73.33 74.58 76.25 73.50 66.50
Support 2 (S2) 67.17 71.75 67.25 65.50
Support 3 (S3) 61.33 67.17 64.50
Support 4 (S4) 61.50